{
  "documents": [
    "original article 2007InternationalSocietyofNephrology Risk factors for chronic Kidney disease in a community-based population: a 10-year follow-up study potassium Yamagata1, potassium Ishida2, T Sairenchi3, H Takahashi4, S Ohba5, T Shiigai6, M Narita5 and A Koyama7 1DepartmentofNephrology, InstituteofClinicalMedicine, GraduateSchoolofComprehensiveHumanSciences, UniversityofTsukuba, Tsukuba, Ibaraki, Japan; 2Department of Health and Welfare, Ibaraki Prefectural Office, Mito, Ibaraki, Japan; 3Ibaraki Health Plaza, Ibaraki Health Service Association, Mito, Ibaraki, Japan; 4Department of Epidemiology, Institute of Community Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan; 5Ibaraki Kidney Foundation, Mito, Ibaraki, Japan; 6Toride Kyodo General Hospital, Toride, Ibaraki, Japan and 7Ibaraki Prefectural University of Medical Sciences, Ami, Ibaraki, Japan Thepurposeofthisstudywastoexploreriskfactorsaffecting The number of the patients with end-stage renal diseases theincidence ofchronic Kidney disease (chronic kidney disease) ingeneral (end-stage renal disease) has increased by about 9% per year in the USA, population. Weconducted a 10-yearfollow-up study with about4%peryearinmostofEuropeancountries, 1andabout 123764 (male: 41012, female: 82752)adultsaged 40years 7% per year in Japan. 2 The increased incidence of end-stage renal disease is and over who received community-based annual recognized as a major public health problem worldwide. To examinations. Theprimaryoutcomefortheanalysiswasthe preventanincreaseinthenumberofESRDpatientsinJapan, developmentofCKDduringthefollow-upperiod. Predictors a dipstick Urine examination has been available annually for forthedevelopmentofCKDwereobtainedbythesignificant every school child since 1973, for every working adult since hazardratios(heart rate)inCoxregressionmodelbysex. Duringthe 1972, and for every resident older than 40 years of age since follow-up period, 4307subjects (male: 2048, female: 2259) 1982 under the auspices of local governments and the developedCKDstageIorII, and19411subjects(male: 4257, Ministry of Health, Labor and Welfare of Japan. Also, an female: 15154)developed chronic kidney disease stageIII orhigher. The annualmeasurementofserumcreatininewasstartedin1992 baseline-adjustedpredictorofdevelopingCKDincludedage, for every resident older than 40 years of age. 3, 4 However, glomerularfiltrationrate, hematuria, hypertension, Diabetes, there have been few reports concerning the effects and serumlipids, obesity, smoking status, and consumptionof outcomes of this screening program. In 2002, the Kidney alcohol. Treated diabetesinmalesubjects, and treated Disease Outcomes Quality Initiative (potassium/DOQI) of the hypertension, systolic Blood Hypertension 4160mmHg and/or National Kidney Foundation (National Kidney Foundation) gave a definition and diastolicbloodpressure4100mmHg, Diabetes, andtreated classification system for chronic Kidney disease (chronic kidney disease). 5 The diabetesinfemalesubjectswereassociatedwithmorethana definition and classification of chronic kidney disease were accepted by the doublingoftheHR. ForthedevelopmentofCKDstageIIIor international board of directors of Kidney Disease: Improvhigher, proteinuriaofXþ þ, andproteinuriaandhematuria ing Global Outcomes (Kidney Disease: Improving Global Outcomes). 6 chronic kidney disease was defined in five wereassociatedwithmorethanadoublingoftheHRinmale stages, based on the appearance of proteinuria and glomesubjects. The prevalence ofnewly developed chronic kidney disease over 10 rular estimated glomerular filtration rate (glomerular filtration rate) levels. To estimate glomerular filtration rate, the years was 23718 subjects(19. 2%) inadults. Thisstudy modification of diet in renal disease (MDRD) formula was suggested thatnot onlyhypertension and Diabetes but also recommended for its accuracy in elderly subjects. 7 It was several metabolicabnormalities were independentrisk estimated that of the 19. 2 million ultrasound adults with chronic kidney disease, factors fordeveloping chronic kidney disease. patients with early-stage chronic kidney disease had no symptoms and the KidneyInternational(2007)71, 159166. doi: 10. 1038/sj. ki. 5002017; majority of individuals in early stage of chronic kidney disease had gone publishedonline22November2006 undiagnosed even in developed countries. 8 Furthermore, KEYWORDS: chronic kidneydisease; proteinuria; riskfactors; epidemiology patients with chronic kidney disease have an increased risk of not only end-stage renal disease, andoutcomes but also poor cardiovascular outcomes and death. 911 Avast numberofthosewithmoderateCKDdiebeforetheydevelop Correspondence: potassium Yamagata, Department of Nephrology, Institute of more advanced chronic kidney disease. 12 Clinical Medicine, Graduate School of Comprehensive Human Sciences, In this study, we used mass screening data from a UniversityofTsukuba, 1-1-1Ten-oudai, Tsukuba, Ibaraki305-8575, Japan. E-mail: Kidneymd. tsukuba. before meals. jp community-based annual health-check held in Ibaraki prefecture, Japan.",
    "E-mail: Kidneymd. tsukuba. before meals. jp community-based annual health-check held in Ibaraki prefecture, Japan. We measured the prevalence of chronic kidney disease and Received 20 June 2006; revised 13 September 2006; accepted 10 October2006; publishedonline22November2006 its yearly changes in subjects who were continuously KidneyInternational(2007)71, 159166 159 original article KYamagataetal. : RiskfactorsforCKD monitored over 10 years. From this study, we found the includedtreatedhypertension (hazardratio (heart rate), 2. 28; 95% yearly incidence of chronic kidney disease in a large community-based popuconfidence interval (CI), 2. 072. 52) in female subjects, lation older than 40 years, and tried to find risk factors for systolic Blood Hypertension 4160mm Hg and/or diastolic Blood the development of chronic kidney disease among the subjects during the Hypertension 4100mm Hg (heart rate, 2. 17; 95% CI, 1. 852. 54) in 10-yearfollow-upperiod. Basedon ourresults, strategies for female subjects, and treated Diabetes (heart rate, 2. 48; 95% CI, effectivemethodstopreventthedevelopmentofCKDamong 2. 122. 91 in male subjects; heart rate, 2. 91; 95% CI, 2. 463. 45 in the general population could be devised. female subjects), which were associated with more than a doubling of the heart rate of developing proteinuria. The heart rate of RESULTS developing proteinuria increased with elevations in Blood Followed-upsubjects Hypertension levels in both genders. In the subjects with The age distribution of the subjects is shown in Figure 1. hypercholesterolemia, Low High-density lipoprotein cholesTable 1 shows baseline characteristics of the follow-up terol (HDL-C), and hypertriglyceridemia, the heart rate of devesubjects. Male subjects were older, more frequently had loping proteinuria increased in both genders. Obesity Diabetes, were hypertensive, and had smoking and drinking habits, whereasfemalesubjectsoftenhadhematuria. Alower number of male subjects was observed in this study because 35 000 Men most male residents under 60 years did not receive their Women annual physical checks at community centers, but at their 30 000 work places. 25 000 Incidence ofCKDstage Ior II 20 000 During the follow-up period, 4307 subjects (male: 2048, female: 2259) developed chronic kidney disease stage I or II. The incidence of 15 000 developing proteinuria also increased with age (Figure 2). 10 000 Male subjects developed chronic kidney disease I or II more frequently than female subjects. The predictors of developing proteinuria 5000 included age, hematuria, hypertension, impaired glucose 0 tolerance (IGT), Diabetes, serum lipids, obesity, smoking 4049 5059 6069 7079 status, and consumption of alcohol (inverse relationship) Figure1Agedistributionofthesubjects. Alowernumberofmale (Table2). Baseline-adjustedpredictorsofdevelopingproteinuria subjectsunder60yearswasobservedinthisstudy. Table1Baselinecharacteristics of the followed up subjectsby sex Male(n41012) Female(n82752) Values s. d. or% Values s. d. or% Meanage, s. d. 61. 8 10. 2 58. 3 10. 0 Creatinine(milligrams per deciliter), s. d. 1. 0 0. 1 0. 8 0. 1 EstimatedGFR(milliliters per minute/1. 73m2), s. d. 81. 9 14. 5 79. 8 14. 2 Proteninuria, n, % 638 1. 6 521 0. 6 Proteninuriaandhematuria, n, % 248 0. 6 399 0. 5 Hematuriaalone, n, % 3424 8. 3 15443 18. 7 Hypertension, n, % 20569 50. 2 31695 38. 3 Treatedhypertension, n, %amonghypertensivesubjects 8613 41. 9 15609 49. 2 Impairedglucosetolerancen, % 6046 14. 7 6998 8. 5 Diabetes, n, % 3007 7. 3 3329 4. 0 Diabetes, withmedication, n, %amongdiabeticsubjects 1468 48. 8 1769 53. 1 Totalcholesterol(milligrams per deciliter), s. d. 193 33. 5 210 34. 7 HDL-C(milligrams per deciliter), s. d. 52. 5 14. 7 56. 8 14. 1 Triglyceride(milligrams per deciliter), s. d. 147. 3 94. 4 136. 5 78. 6 Bodymassindex(kg/m2), s. d. 23. 2 2. 9 23. 5 3. 2 Smoking Current, n, % 19372 47. 2 3437 4. 2 Previous, n% 12104 29. 5 441 0. 5 Alcoholconsumption Occasionaln, % 5223 12. 7 4813 5.",
    "96 0. 801. 14 0. 637 Ethanolo20g/day 0. 86 0. 780. 95 0. 002 0. 80 0. 631. 02 0. 0685 Ethanol420g/day 1. 04 0. 861. 25 0. 5057 1. 05 0. 264. 24 0. 9444 blood pressure, bloodpressure; CI, confidenceinterval; chronic kidney disease, chronickidneydisease; HDL-C, High-densitylipoproteincholesterol; heart rate, hazardratio; IGT, impairedglucosetolerance. Po0. 05. KidneyInternational(2007)71, 159166 161 original article KYamagataetal. : RiskfactorsforCKD Incidence ofCKDstage IIIor higher tors of developing chronic kidney disease stage III or higher included During the follow-up period, 19411 subjects (male: 4257, proteinuria (Xþ þ) (heart rate, 2. 26; 95% CI, 1. 712. 99), concofemale: 15154) exhibited GFRo60ml/min/1. 73m2. The mitant proteinuria, and hematuria (heart rate, 2. 32; 95% CI, incidence of chronic kidney disease stage III or higher increased with age 1. 812. 97)inmalesubjects, whichwereassociatedwithmore (Figure 4). The predictors of developing chronic kidney disease stage III or than a doubling of the heart rate. Treated hypertension increased higher were age, proteinuria, hematuria, hypertension, treathe heart rate of developing renal failure by 39%, and treated ted Diabetes, and smoking status. Baseline-adjusted predicDiabetes increased the heart rate by 20%; however, alcohol consumption of less than 20g/day decreased the heart rate of 35. 0% developing chronic kidney disease stage III or higher by 8% in male subjects Male and 9% in female subjects. Treated hypertension increased 30. 0% Female the heart rate of developing chronic kidney disease stage III or higher by 39% (20% 25. 0% in female), and taking Diabetes medication increasedthe heart rate 20. 0% by 20% in male subjects and 12% in female subjects. A 15. 0% reduced risk fordeveloping chronic kidney disease stage IIIin IGTordiabetes 10. 0% was observed (Table 3). 5. 0% Figure 5 shows the yearly incidence of chronic kidney disease stage III or 0. 0% higher among the follow-up subjects. In the early years of 4049 5059 6069 70 follow-up, ahigherincidenceofdevelopingCKDstageIIIor Figure4Age-specificincidencerateofCKDstageIIIorhigherby higher was also observed. However, after 1998, the yearly sex. Duringthefollow-upperiod, 19411(male: 4257, female: 15154) exhibitedGFRo60ml/min/1. 73m2. TheincidenceofCKDstageIIIor incidenceofCKDstageIIIorhigherwasabout0. 8%peryear higherincreasedwithage. in male subjects and about 1. 5% per year in female subjects. Table3Thepredictors for developing chronic kidney disease stageIIIor higher during10-year follow-up period Male Female Predictors heart rate 95%CI P heart rate 95%CI P Age 1. 03 1. 031. 04 o0. 0001 1. 05 1. 051. 06 o0. 0001 glomerular filtration rate 0. 87 0. 870. 88 o0. 0001 0. 90 0. 890. 90 o0. 0001 Proteinuria((cid: 2)) 1. 00 1. 00 Proteinuria() 1. 66 1. 342. 07 o0. 0001 1. 36 1. 101. 69 0. 0046 Proteinuria4 2. 26 1. 712. 99 o0. 0001 1. 78 1. 372. 30 o0. 0001 Proteinuriaandhematuria 2. 32 1. 812. 97 o0. 0001 1. 43 1. 181. 73 0. 0003 Hematuria((cid: 2)) 1. 00 1. 00 Hematuria() 1. 23 1. 101. 39 0. 0004 1. 07 1. 021. 13 0. 0043 Hematuria4 1. 31 1. 151. 50 o0. 0001 1. 07 1. 011. 12 0. 0128 blood pressure(cid: 2)140/(cid: 2)90mmHg 1. 00 1. 00 BP140150/9095mmHg 1. 13 1. 041. 23 0. 0035 1. 08 1. 041. 14 0. 0007 BP150160/95100mmHg 1. 17 1. 051. 29 0. 0034 1. 19 1. 121. 26 o0. 0001 BP160/100mmHg 1. 33 1. 191. 48 o0. 0001 1. 26 1. 171. 35 o0. 0001 Treatedhypertention 1. 39 1. 301. 50 o0. 0001 1. 20 1. 161. 25 o0. 0001 IGT((cid: 2)) 1. 00 1. 00 IGT() 0. 86 0. 790. 93 0. 0002 0. 80 0. 760. 85 o0. 0001 Diabetes((cid: 2)) 1. 00 1. 00 Diabetes() 0. 71 0. 610. 84 o0. 0001 0. 76 0. 680. 86 o0. 0001 Treateddiabetes 1. 20 1. 051.",
    "71 0. 610. 84 o0. 0001 0. 76 0. 680. 86 o0. 0001 Treateddiabetes 1. 20 1. 051. 38 o0. 0001 1. 12 1. 011. 24 o0. 0001 Hypercholesterolemia((cid: 2)) 1. 00 1. 00 Hypercholesterolemia() 1. 01 0. 941. 08 0. 8865 0. 95 0. 920. 98 0. 0026 LowHDL-C((cid: 2)) 1. 00 1. 00 LowHDL-C() 1. 10 1. 031. 19 0. 0084 1. 02 0. 971. 08 0. 4101 Hypertriglyceridemia((cid: 2)) 1. 00 1. 00 Hypertriglyceridemia() 1. 04 0. 981. 11 0. 2121 1. 10 1. 071. 14 o0. 0001 Obesity((cid: 2)) 1. 00 1. 00 Obesity() 1. 03 0. 961. 10 0. 3979 1. 06 1. 031. 10 0. 0006 Neversmoking 1. 00 1. 00 Previoussmoking 1. 05 0. 971. 13 0. 2232 1. 10 0. 881. 37 0. 4007 Currentsmoking 1. 13 1. 051. 22 0. 0007 1. 16 1. 061. 26 0. 0009 Neverdrinker 1. 00 1. 00 Occasionaldrinker 0. 96 0. 881. 05 0. 3721 0. 89 0. 830. 97 0. 0052 Ethanolo20g/day 0. 92 0. 860. 98 0. 0065 0. 91 0. 831. 00 0. 0414 Ethanol420g/day 0. 93 0. 791. 10 0. 4214 0. 59 0. 221. 56 0. 2846 blood pressure, bloodpressure; CI, confidenceinterval; chronic kidney disease, chronickidneydisease; HDL-C, High-densitylipoproteincholesterol; heart rate, hazardratio; IGT, impairedglucosetolerance. Po0. 05. 162 KidneyInternational(2007)71, 159166 KYamagataetal. : RiskfactorsforCKD original article 4. 5% andtheMinistryofHealth, LaborandWelfareofJapan. Our Male study demonstrated that 23718 subjects (19. 2%) had deve4. 0% Female loped chronic kidney disease during the 10-year follow-up period. Predicting 3. 5% factors for the development of chronic kidney disease showed a slight 3. 0% difference between chronic kidney disease stage I and II (proteinuria), and chronic kidney disease stage III or higher, as well as between genders. Age, 2. 5% bloodpressurelevels, andsmokinghabitshadthesameeffect 2. 0% on all of chronic kidney disease stages. However, Diabetes, obesity, hyperlipidemia, and alcohol consumption had different effects on the 1. 5% incidence of each chronic kidney disease stage. 1. 0% The prevalence of proteinuria and renal failure were 0. 5% influenced by age and gender. 13, 14 Age is recognized as an independentriskfactorforrenaldisease15andourfindingsof 0. 0% 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 increased incidence of proteinuria with aging are consistent Number of followed up subjects in end of each year with previous reports. 13, 1618 Also, an increased incidence of Male 40 015 39 309 38 419 37 682 37 370 36 923 36 659 36 466 36 309 36 012 renal dysfunction with aging is consistent with previous Female79 679 77 608 74 922 72 511 71 584 69 992 68 854 68 076 67 568 66 589 reports. In subjects older than 50 years, the percentage of Figure5TrendofannualincidencerateofCKDstageIIIor scleroticglomeruli increased, with a range of 0. 536%, 19due higherbysex. Intheearlyyearsoffollow-up, ahigherincidenceof to glomerular ischemia secondary to the changes in renal developingCKDstageIIIorhigherwasalsoobserved. However, after 1998, theyearlyincidenceofCKDstageIIIorhigherwasabout0. 8% bloodflowthatoccurwithaging. 20, 21Thesechangesresulted formalesubjectsandabout1. 5%forfemalesubjects. innotonlyprogressiverenaldysfunctionbutalsoproteinuria due to glomerular hypertension and hyperfiltration of residual glomeruli. Table4Prevalence of newlydeveloped CKDamongthe Proteinuria and hypertension are recognized as strong subjects predictors for progression of renal dysfunction. 22 Klag et al. reported a strong, graded relationship between Blood Age(years) pressureandESRDinmen. 23Wefoundagradedrelationship 4049 5059 6069 70 Total % between Blood Hypertension and newly onset chronic kidney disease in both Male genders. Furthermore, thesubjectswithtreatedhypertension StageI 64 94 147 22 327 0. 82 had a higher risk for developing chronic kidney disease than other hyperStageII 147 276 867 431 1721 4. 30 StageIII 105 540 2343 1467 4257 10. 38 tensivesubjects: thesesubjectsmayhavehadalong-standing history of hypertension resulting in vascular damage.",
    "30 StageIII 105 540 2343 1467 4257 10. 38 tensivesubjects: thesesubjectsmayhavehadalong-standing history of hypertension resulting in vascular damage. Recent Female studies have suggested that strict Blood Hypertension control and StageI 93 141 52 9 295 0. 36 StageII 213 490 876 385 1964 2. 41 certain classes of antihypertensive medications, such as StageIII 742 3531 8063 3065 15154 18. 31 angiotensin-converting enzyme inhibitors or angiotensin chronic kidney disease, chronickidneydisease. receptor antagonists, reduce proteinuria and prevent progression to end-stage renal disease. 22 In this study, we had no information about any antihypertensive drugs which the treated hyperPrevalence ofCKD amongthe cohorts tensive subjects might have been taking. Further prospective During the 10-year follow-up period, we found that 327 studies are needed to clarify the effectiveness of strict Blood subjects had chronic kidney disease stage I, 1721 subjects had chronic kidney disease stage II, Hypertension control, or certain classes of antihypertensive mediand4455subjectshadCKDstageIIIorhigher, ofwhom198 cation such as angiotensin-converting enzyme inhibitors subjects already had proteinuria at the baseline (Table 4). or angiotensin receptor antagonists, on the development Consequently, 4257 male subjects newly developed chronic kidney disease of chronic kidney disease. stage III or higher. We found that 295 female subjects had Diabetes is also considered to be a predictor for developchronic kidney disease stage I, 1964 had chronic kidney disease stage II, and 15401 had chronic kidney disease ingproteinuria13, 18andprogressiontorenaldysfunction. 24, 25 stage III or higher, of whom 247 already had proteinuria at Our findings of an increased incidence of proteinuria with the baseline. Consequently, 15154 female subjects newly Diabetes are consistent with previous reports. However, a developedCKDstageIIIorhigher. Overall, theprevalenceof reduced risk fordeveloping chronic kidney disease stage IIIin IGTordiabetes newly developed chronic kidney disease over the 10 years was 23718 subjects was observed. In general, patients with Diabetes exhibited (19. 2%) over 40 years of age. smallamountofalbuminintheirurinein2040%ofpatients withtypeIortypeIIdiabetesafter1015yearsofstablerenal DISCUSSION function or even hyperfiltration. 26 Consequently, some The subjects in the present study were a large group of subjects with IGT or Diabetes showed hyperfiltration, and community-based individuals who underwent annual health these subjects maintained their renal function within the examinations under the auspices of the local governments normalrange, whereaspatientstreatedfordiabetes, whohad KidneyInternational(2007)71, 159166 163 original article KYamagataetal. : RiskfactorsforCKD long-standing diabetic status, often progressed to chronic kidney disease stage developing renal dysfunction only in female subjects over III or higher during the follow-up period. a 10-year follow-up period. Consequently, it is possible Hyperlipidemia is also considered to be a risk factor that obesity might be a significant relative risk for renal for developing chronic kidney disease. 25, 27 Although hypertriglyceridemia is dysfunction after a longer follow-up duration in both regarded as an independent risk factor for developing genders. proteinuria, 28, 29 the effect of total cholesterol and HDL-C Smoking is an independent risk factor for the developon proteinuria development is controversial. 18 Metcalf et al. ment of chronic kidney disease. 36 Our cohort also showed that smoking reported that the degree of albuminuria showed piecewise induced increased the risk of proteinuria and renal dysfunclog-linearrelationshipswithhypertriglyceridemiaandhypertioninbothgenders. However, beinganex-smokerwasnota cholesterolemia, and a negative piecewise linear relationship risk factor for developing proteinuria and renal dysfunction. with HDL-C. 17 On the contrary, Tozawa et al. reported that Consequently, cessation of smoking has a favorable effect hypertriglyceridemia was a significant predictor of Proteinon preventing the development of chronic kidney disease. uria, but hypercholesterolemia and Low HDL-C were not Several population-based studies have suggested that within three years follow-up period. 28 The effect of hypermoderate alcohol intake has a protective effect on cardiolipidemia on progression of renal dysfunction produced vascular death. 37, 38 The effects of alcohol consumption on more complex results.",
    "Iseki et al. 34 reported that obesity 10 years was 23718 (19. 2%) in adults over 40 years of age. was not a major risk factor for development of end-stage renal disease in a The subjects of the present study were a large group of 10-year follow-up period. Recently, Fox et al. 30 and Iseki community-based individuals who underwent annual health et al. 35 reported that obesity was an independent risk factor examinations under the auspices of the local governments for development for renal dysfunction following 1718. 5 and the Ministry of Health, Labor and Welfare of Japan. We years follow-up. Our cohorts showed a 6% increased risk of found several significant risk factors for developing chronic kidney disease. 164 KidneyInternational(2007)71, 159166 KYamagataetal. : RiskfactorsforCKD original article Blood Hypertension levels, Diabetes status, serum lipid status, glomerular filtration rate was estimated from adjusted serum Creatinine using the obesity, smoking, and alcohol consumption affected the simplified equation developed from theMDRD Study7 asfollows: development of chronic kidney disease. Further studies are needed to clarify glomerular filtration rate (milliliters per minute/1. 73m2)¼186. 3(cid: 4)(serum Creatinine)(cid: 2)1. 154(cid: 4) age(cid: 2)0. 203(cid: 4)(0. 742for femalesubjects). the effects of controlling these risk factors on the prevention The serum Creatinine value used for the MDRD equation was of chronic kidney disease. measuredattheClevelandClinicLaboratoryasthemeasurementof serum Creatinine can vary across different laboratories. Serum MATERIALSAND METHODS Creatinine was calibrated as previously described. 30 First, the Subjects National Health and Nutrition Examination Survey III Creatinine Allthesubjectsinthisstudywereparticipantsintheannualhealth value was calibrated to the Cleveland Clinic Laboratory, requiring examination held in Ibaraki prefecture, Japan, between 1993 and a correction factor of 0. 23mg/dl. Then, mean Creatinine values 2003. Attheinitialscreening, atotalof191006adults(male: 65368, from our study, by gender-specific age groups, were aligned with female: 125698)aged40yearsoroverunderwentanannualhealth the corresponding corrected National Health and Nutrition examination at the Ibaraki health-care center in 1993. The study Examination Survey III age-specific and sex-specific means. protocol was approved by the Ethics Committee of Ibaraki Overall mean differences between National Health and Nutrition PrefecturalOffice. CKDanditsstagesweredefinedfromestimated Examination Survey III and our cohort were 0. 17mg/dl. Conseglomerular filtration rate of o60ml/min/1. 73m2 or dipstick proteinuria (X1þ) as quently, we reduced 0. 06 from each Creatinine value before follows: Stage1CKDwasdefinedasanestimated(e)GFRX90ml/ calculating glomerular filtration rate. min/1. 73m2andproteinuria. Stage2CKDwaseGFR6089ml/min/ Measurements of Blood glucose, total cholesterol, triglycerides, 1. 73m2andproteinuria. Stages35CKDwereclassifiedtothelevel and HDL-C were measured using an autoanalyzer (Hitachi 7350, of Kidney function (estimated glomerular filtration rate 3059, 1529, and o15ml/min/1. 73m2, Hitachi Ltd, Tokyo, Japan or treatment/prescription-20, JEOL Ltd, Tokyo, Japan). respectively), regardless of the presence of other markers of Kidney HypertensionwasdefinedaccordingtoWorldHealthOrganizadamage. 5 tion Blood Hypertension criteria and the use of antihypertensive The number of patients with chronic kidney disease and the classifications of all medications in 1993 as follows: subjects taking antihypertensive participantsattheinitialscreeningin1993areshowninTable5. In medication at the baseline were defined as hypertension-treated total, 5521 male subjects of 65368 subjects (8. 4%) had chronic kidney disease and (treated hypertension); subjects having systolic Blood Hypertension 11454femalesubjectsof125698(9. 1%)hadCKD. Forthefollow-up X140mm Hg and diastolic Blood Hypertension X90mm Hg were study, weexcludedsubjectswhoalreadyhadCKDstageIIIandover, defined as hypertensive. Diabetes was defined as follows: subjects and67302(male: 24356, female: 42936)whodidnotreceiveannual who were receiving oral hypoglycemic or insulin treatment were examinations continuously. For the follow-up study on developing defined as treated Diabetes; subjects with fasting Blood sugarX proteinuria, 1806 (male: 886, female: 920) were excluded because 126mg/dl or random Blood sugarX200mg/dl were defined as theyhadproteinuria(CKDIorII)attheinitialscreeningin1993. diabetic; subjects with fasting Blood Glucose levels between 110 All subjects were interviewed to obtain information regarding and 126mg/dl or random Blood Glucose level between 140 and alcoholintake, smokinghabits, andmedicalhistory, includinguseof 200mg/dl were defined as IGT. Hypercholesterolemia was defined antihypertensive and Diabetes medications.",
    "Hypercholesterolemia was defined antihypertensive and Diabetes medications. Blood Hypertension was as total cholesterolX220mg/dl, Low HDL-C was defined as HDLmeasured after several minutes rest in a sitting position with a Cp35mg/dl, and hypertriglyceridemia was defined as triglycerides mercury sphygmomanometer or automatic device. The Blood X250mg/dl. pressuremeasurement wasrepeated if thefirst reading wasoutside Alcoholintakewasdefinedasfollows: totalalcoholconsumption thenormal range. in grams per day was calculated from questions on the number of Proteinuria and hematuria were tested using dipsticks (Ames glasses of wine, beer, fortified wines, sake, and liqueurs/spirits per Hemacombisticks; Bayer-SankyoLtd, Tokyo, Japan). Atestresultof day. Oneglassofanyalcoholicbeveragewasassumedtocontain10g 1þormorewasdefinedaspositive. Serumcreatinineconcentraof alcohol. The total alcohol consumption was then classified into tion was measured by a modified Jaffe method (Creatinine heart rate, four categories: No alcohol consumption, occasional alcohol Wako Pure Chemicals Industries, Ltd, Osaka, Japan) using an consumption, lessthan 20g/day, and more than 20g/day. autoanalyzer (Hitachi 7350, Hitachi Ltd, Tokyo, Japan or treatment/prescription-20, Smokinghabitswereclassifiedintothreecategories: non-smoker, JEOL Ltd, Tokyo, Japan). The median for serum Creatinine was previoussmoker, orcurrentsmoker. Obesitywasdefinedasabody 1. 0mg/dl for male subjects and 0. 8mg/dl for female subjects over mass index X25kg/m2, calculated as body weight in kilograms the10yearsof thestudy. dividedby thesquare oftheheightinmeters. Table5Classification ofCKD among191066 adultsat initial screeningheld in 1993 Male Female Stage n % Meanage(years) Agerange(years) n % Meanage(years) Agerange(years) I 365 0. 6 58 4086 338 0. 3 52 4079 II 1340 2. 0 65 4094 1519 1. 2 63 4089 III 3724 5. 7 71 4098 9487 7. 5 70 4096 IV 65 0. 1 73 5391 95 0. 1 70 4191 V 27 0. 0 68 4588 15 0. 0 65 4283 Total 5521 8. 4 11454 9. 1 chronic kidney disease, chronickidneydisease. KidneyInternational(2007)71, 159166 165 original article KYamagataetal. : RiskfactorsforCKD Statisticalmethods 15. NeugartenJ, GalloG, SilbigerSetal. Glomerulosclerosisinaginghumans isnotinfluencedbygender. AmJKidneyDis1999; 34: 884888. The primary outcome for the analysis was an estimate of 16. RamirezSP, McClellanW, PortFKetal. Riskfactorsforproteinuriain GFRo60ml/min/1. 73m2. (chronic kidney disease stage III or higher) and the alarge, multiracial, southeastAsianpopulation. JAmSocNephrol2002; development of proteinuria (chronic kidney disease stage I or II) during the follow13: 19071917. up period. Variables were age, proteinuria (categorized as ((cid: 2), þ, 17. MetcalfP, BakerJ, ScottAetal. Albuminuriainpeopleatleast40years old: effectofobesity, hypertension, andhyperlipidemia. ClinChem1992; and þ þ), ormore), hematuria(categorizedas((cid: 2), þ, and þ þ), 38: 18021808. or more), concomitant proteinuria and hematuria ((cid: 2), þ), IGT 18. deJongPE, BrennerBM. Fromsecondarytoprimarypreventionof ((cid: 2), þ), Diabetes((cid: 2), þ, andtreateddiabetes), hypertension(categorprogressiverenaldisease: thecaseforscreeningforalbuminuria. Kidney izedassystolicbloodpressure(cid: 2)140mmHgand/ordiastolicblood Int2004; 66: 21092118. 19. KappelB, OlsenS. Corticalinterstitialtissueandsclerosedglomeruliinthe Hypertension(cid: 2)90mmHg, systolicbloodpressure140150mmHgand/ normalhumankidney, relatedtoageandsex. Aquantitativestudy. or diastolic Blood Hypertension 9095mm Hg, systolic Blood Hypertension VirchowsArchAPatholAnatHistol1980; 387: 271277. 150160mm Hg and/or diastolic Blood Hypertension 95100mm Hg, 20. DontasAS, MarketosSG, PapanayiotouP. Mechanismsofrenaltubular systolic Blood Hypertension 160mm Hg and/ordiastolic Blood Hypertension defectsinoldage. PostgradMedJ1972; 48: 295303. 21. McLachlanMS, GuthrieJC, AndersonCKetal. Vascularandglomerular 100mm Hg and treated hypertension), hypercholesterolemia changesintheageingkidney. JPathol1977; 121: 6578. ((cid: 2), þ), lowHDL-C((cid: 2), þ), hypertriglyceridemia((cid: 2), þ), obesity 22. RuggenentiP, SchieppatiA, RemuzziG. Progression, remission, ((cid: 2), þ), cigarette smoking (never, previous smoker, and current regressionofchronicrenaldiseases. Lancet2001; 357: 16011608. smoker), alcohol consumption (never, occasional drinker, alcohol 23. KlagMJ, WheltonPK, RandallBLetal. Bloodpressureandend-stagerenal consumptiono20g/day, and alcohol consumptionX20g/day). In diseaseinmen. NEnglJMed1996; 334: 1318. 24. IsekiK, OshiroS, TozawaMetal. Prevalenceandcorrelatesofdiabetes thefollow-upstudyofproteinuria, GFRwasincludedasavariable, mellitusinascreenedcohortinOkinawa, Japan. HypertensRes2002; 25: but proteinuria, and concomitant proteinuria and hematuria were 185190. excluded from the variables. HRs of renal failure development or 25. MuntnerP, CoreshJ, SmithJCetal. Plasmalipidsandriskofdeveloping proteinuria development by sex were estimated by using Cox renaldysfunction: theatherosclerosisriskincommunitiesstudy. Kidney Int2000; 58: 293301. regressionmodelafterconfirmingtheproportionalityineachmodel 26. RemuzziG, BenigniA, RemuzziA. Mechanismsofprogressionand (SASsoftware, version8. 3, SASInstituteInc. , calcium, USA). Ifavariable regressionofrenallesionsofchronicnephropathiesanddiabetes. JClin wascategorical, thefirstcategoryintheparenthesisintheprevious Invest2006; 116: 288296. definitionwasdefinedasthebaselineintheCoxmodel. AP-valueof 27. SchaeffnerES, KurthT, CurhanGCetal. Cholesterolandtheriskofrenal dysfunctioninapparentlyhealthymen. JAmSocNephrol2003; 14: lessthan 0. 05 wasconsideredstatistically significant. 20842091. 28. TozawaM, IsekiK, IsekiCetal.",
    "AP-valueof 27. SchaeffnerES, KurthT, CurhanGCetal. Cholesterolandtheriskofrenal dysfunctioninapparentlyhealthymen. JAmSocNephrol2003; 14: lessthan 0. 05 wasconsideredstatistically significant. 20842091. 28. TozawaM, IsekiK, IsekiCetal. Triglyceride, butnottotalcholesterol REFERENCES orlow-densitylipoproteincholesterollevels, predictdevelopmentof 1. JungersP. Screeningforrenalinsufficiency: isitworthwhile? isit proteinuria. Influenceofsmokingandobesityonthedevelopmentof feasible? NephrolDialTransplant1999; 14: 20822084. proteinuria. KidneyInt2002; 62: 17431749. 2. AkibaT, NakaiS, ShinzatoTetal. Whyhasthegrossmortalityofdialysis 29. ChenJ, MuntnerP, HammLLetal. Themetabolicsyndromeandchronic patientsincreasedinJapan? KidneyInt2000; 57(Suppl74): S60S65. kidneydiseaseinUSadults. AnnInternMed2004; 140: 167174. 3. YamagataK, TakahashiH, TomidaCetal. Prognosisofasymptomatic 30. FoxCS, LarsonMG, LeipEPetal. Predictorsofnew-onsetkidneydisease hematuriaand/orproteinuriainmen. Nephron2002; 91: 3442. inacommunity-basedpopulation. JAMA2004; 291: 844850. 4. IshidaK, IshidaH, NaritaMetal. Factorsaffectingrenalfunctionin 31. AthyrosVG, MikhailidisDP, PapageorgiouAAetal. Theeffectofstatins 119985adultsoverthreeyears. QJMed2001; 94: 541550. versusuntreateddyslipidaemiaonrenalfunctioninpatientswith 5. potassium/DOQIClinicalPracticeGuidelinesforChronicKidneyDisease: coronaryheartdisease. AsubgroupanalysisoftheGreekatorvastatinand evaluation, classification, andstratification. Part5. Evaluationof coronaryheartdiseaseevaluation(GREACE)study. JClinPathol2004; 57: laboratorymeasurementsforclinicalassessmentofkidneydisease. 728734. AmJKidneyDis2002; 39: 76110. 32. FriedLF, OrchardTJ, KasiskeBL. Effectoflipidreductiononthe 6. LeveyAS, EckardtKU, TsukamotoYetal. Definitionandclassification progressionofrenaldisease: ameta-analysis. KidneyInt2001; 59: ofchronickidneydisease: apositionstatementfromKidneyDisease: 260269. ImprovingGlobalOutcomes(Kidney Disease: Improving Global Outcomes). KidneyInt2005; 67: 20892100. 33. KambhamN, MarkowitzGS, ValeriAMetal. Obesity-related 7. LeveyAS, BoschJP, LewisJBetal. Amoreaccuratemethodtoestimate glomerulopathy: anemergingepidemic. KidneyInt2001; 59: 14981509. glomerularfiltrationratefromserumcreatinine: anewprediction 34. IsekiK, IkemiyaY, FukiyamaK. Predictorsofend-stagerenaldiseaseand equation. ModificationofdietinRenalDiseaseStudyGroup. AnnIntern bodymassindexinascreenedcohort. KidneyInt1997; 63(Suppl66): Med1999; 130: 461470. S169S170. 8. SchieppatiA, RemuzziG. Chronicrenaldiseasesasapublichealth 35. IsekiK, IkemiyaY, KinjoKetal. Bodymassindexandtheriskof problem: epidemiology, social, andeconomicimplications. KidneyInt developmentofend-stagerenaldiseaseinascreenedcohort. KidneyInt 2005; 67(Suppl98): S7S10. 2004; 65: 18701876. 9. WeinerDE, TighiouartH, AminMGetal. Chronickidneydiseaseasarisk 36. OrthSR. Smokingandthekidney. JAmSocNephrol2002; 13: 16631672. factorforcardiovasculardiseaseandall-causemortality: apooledanalysis 37. BurchfielCM, TracyRE, ChyouPHetal. Cardiovascularriskfactorsand ofcommunity-basedstudies. JAmSocNephrol2004; 15: 13071315. hyalinizationofrenalarteriolesatautopsy. TheHonoluluHeartProgram. 10. JafarTH, StarkPC, SchmidCHetal. Progressionofchronickidney ArteriosclerThrombVascBiol1997; 17: 760768. disease: theroleofbloodpressurecontrol, proteinuria, and 38. MalinskiMK, SessoHD, Lopez-JimenezFetal. Alcoholconsumptionand angiotensin-convertingenzymeinhibition: apatient-levelmeta-analysis. cardiovasculardiseasemortalityinhypertensivemen. ArchInternMed AnnInternMed2003; 139: 244252. 2004; 164: 623628. 11. IsekiK, IkemiyaY, IsekiCetal. Proteinuriaandtheriskofdeveloping 39. KnightEL, StampferMJ, RimmEBetal. Moderatealcoholintakeandrenal end-stagerenaldisease. KidneyInt2003; 63: 14681474. functiondeclineinwomen: aprospectivestudy. NephrolDialTransplant 12. FoleyRN, MurrayAM, LiSetal. Chronickidneydiseaseandtheriskfor 2003; 18: 15491554. cardiovasculardisease, renalreplacement, anddeathintheUnitedStates 40. PernegerTV, WheltonPK, PuddeyIBetal. Riskofend-stagerenaldisease Medicarepopulation, 1998to1999. JAmSocNephrol2005; 16: 489495. associatedwithalcoholconsumption. AmJEpidemiol1999; 150: 13. TozawaM, IsekiK, IsekiCetal. Influenceofsmokingandobesityonthe 12751281. developmentofproteinuria. KidneyInt2002; 62: 956962. 41. WarnockDG, McClellanW, McClureLAetal. Prevalenceofchronickidney 14. YamagataK, TakahashiH, SuzukiSetal. Agedistributionandyearly diseaseandanemiaamongparticipantsintheReasonsforGeographic changesintheincidenceofend-stagerenaldiseaseinJapan. AmJKidney andRacialDifferencesinStroke(REGARDS)CohortStudy: baselineresults. Dis2004; 43: 433443. KidneyInt2005; 68: 14271431. 166 KidneyInternational(2007)71, 159166"
  ],
  "metadatas": [
    {
      "source": "1-s2.0-S0085253815523272-main (1).pdf",
      "chunk_id": 0,
      "content_type": "dietary",
      "content_type_confidence": 4,
      "word_count": 590,
      "entity_count": 8,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,glomerular filtration rate,end-stage renal disease,proteinuria,potassium,diet,screening,classification",
      "year": "2007",
      "organization": "Unknown"
    },
    {
      "source": "1-s2.0-S0085253815523272-main (1).pdf",
      "chunk_id": 1,
      "content_type": "evidence",
      "content_type_confidence": 3,
      "word_count": 595,
      "entity_count": 3,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,proteinuria,creatinine",
      "year": "2007",
      "organization": "Unknown"
    },
    {
      "source": "1-s2.0-S0085253815523272-main (1).pdf",
      "chunk_id": 2,
      "content_type": "reference",
      "content_type_confidence": 2,
      "word_count": 599,
      "entity_count": 4,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,glomerular filtration rate,renal failure,proteinuria",
      "year": "2007",
      "organization": "Unknown"
    },
    {
      "source": "1-s2.0-S0085253815523272-main (1).pdf",
      "chunk_id": 3,
      "content_type": "evidence",
      "content_type_confidence": 3,
      "word_count": 587,
      "entity_count": 3,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,renal failure,proteinuria",
      "year": "2007",
      "organization": "Unknown"
    },
    {
      "source": "1-s2.0-S0085253815523272-main (1).pdf",
      "chunk_id": 4,
      "content_type": "evidence",
      "content_type_confidence": 5,
      "word_count": 599,
      "entity_count": 6,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,renal function,end-stage renal disease,albuminuria,proteinuria,antihypertensive",
      "year": "2007",
      "organization": "Unknown"
    },
    {
      "source": "1-s2.0-S0085253815523272-main (1).pdf",
      "chunk_id": 6,
      "content_type": "treatment",
      "content_type_confidence": 4,
      "word_count": 598,
      "entity_count": 10,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,glomerular filtration rate,kidney function,end-stage renal disease,proteinuria,creatinine,serum creatinine,nutrition,insulin,antihypertensive",
      "year": "2007",
      "organization": "Unknown"
    },
    {
      "source": "1-s2.0-S0085253815523272-main (1).pdf",
      "chunk_id": 7,
      "content_type": "treatment",
      "content_type_confidence": 3,
      "word_count": 599,
      "entity_count": 7,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,renal failure,proteinuria,creatinine,calcium,serum creatinine,antihypertensive",
      "year": "2007",
      "organization": "Unknown"
    },
    {
      "source": "1-s2.0-S0085253815523272-main (1).pdf",
      "chunk_id": 8,
      "content_type": "evidence",
      "content_type_confidence": 4,
      "word_count": 312,
      "entity_count": 3,
      "has_ckd": false,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "proteinuria,potassium,classification",
      "year": "2007",
      "organization": "Unknown"
    }
  ],
  "ids": [
    "1_s2.0_s0085253815523272_main (1)_0",
    "1_s2.0_s0085253815523272_main (1)_1",
    "1_s2.0_s0085253815523272_main (1)_2",
    "1_s2.0_s0085253815523272_main (1)_3",
    "1_s2.0_s0085253815523272_main (1)_4",
    "1_s2.0_s0085253815523272_main (1)_6",
    "1_s2.0_s0085253815523272_main (1)_7",
    "1_s2.0_s0085253815523272_main (1)_8"
  ]
}